share_log

HC Wainwright & Co. Maintains Buy on Connect Biopharma Hldgs, Raises Price Target to $8

HC Wainwright & Co. Maintains Buy on Connect Biopharma Hldgs, Raises Price Target to $8

HC Wainwright & Co.维持对Connect Biopharma Hldgs的买入,将目标股价上调至8美元
Moomoo 24/7 ·  04/17 06:40

HC Wainwright & Co. analyst Emily Bodnar maintains Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy and raises the price target from $7 to $8.

HC Wainwright & Co. 分析师艾米丽·博德纳尔维持Connect Biopharma Hldgs(纳斯达克股票代码:CNTB)的买入并将目标股价从7美元上调至8美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发